The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...
Proposed new rules would punish the hospitals by pulling all federal financing. Advocates say lawsuits will follow.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback